[Physiopathologic and pharmacodynamic rationale for the use of nitrate compounds in cardiac decompensation].
Geraci
E
E
Divisione di Cardiologia, Ospedale Cervello, Palermo.
D000818:Animals; D003326:Coronary Circulation / Q000187:drug effects*; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D009566:Nitrates / Q000494:pharmacology* / Q000627:therapeutic use; D014664:Vasodilation / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use
D009566:Nitrates; D014665:Vasodilator Agents